Southeast Asia’s rising share of global trial volume
Why sponsors are diversifying geographies, and where the Philippines fits in the regional shift.
Insights
Notes on running trials in emerging markets
Writing on clinical research, regulatory pathways, and biopharma intelligence.
Where oncology, infectious disease & vaccine sites are ready
A view of therapeutic areas with the deepest investigator experience and accredited facilities.
Inside the Philippine FDA & ethics review timeline
What the streamlined submission pathway looks like in practice, and where local guidance saves weeks.
Treatment-naïve populations and faster first-patient-in
How large urban sites and motivated patients compress recruitment timelines versus saturated markets.
Why per-patient costs run 30–50% below US/EU sites
A breakdown of site, labor, and overhead deltas that make the same protocol dramatically cheaper to run.